Loading organizations...
Loading organizations...
Black Opal Ventures: venture capital firm investing in early-stage companies for healthcare and biosecurity, focused on AI and machine learning.
Based in New York, Black Opal Ventures is an early-stage venture capital firm that invests in companies utilizing advanced technologies to address complex healthcare and biosecurity challenges. The firm targets innovations across medical diagnosis, drug discovery, and care delivery by backing startups focused on artificial intelligence, machine learning, digital twins, and edge computing. To support these initiatives, the firm operates an inaugural health-tech fund that raised between $58 million and $62 million in total capital commitments. Its institutional investor base includes prominent corporate backers such as Eli Lilly and Company, Bank of America, and Atlantic Health System Venture Studio. The firm deploys this capital into a portfolio of technology-driven healthcare enterprises, which includes notable investments in Twist Bioscience and Cerebras. Black Opal Ventures was founded in 2021 by Dr. Tara Bishop and Eileen Tanghal.
Key people at Black Opal Ventures.
Black Opal Ventures is a New York-based venture capital firm founded in 2021 that invests in early-stage companies leveraging frontier and deep technologies to solve complex challenges, primarily in healthcare and security sectors. Their mission centers on improving health outcomes and addressing unsolved problems by supporting startups at the intersection of science and technology, with a focus on scalable, precise, personalized, and inclusive innovations. The firm actively fosters advancements in diagnostics, treatment, and patient care through investments in companies such as Ansa Biotechnologies and Blaze.Tech, aiming to reshape the future of healthcare globally[1][3][4].
The firm was co-founded by Dr. Tara Bishop and Eileen Tanghal, who lead its vision to back pioneering startups that challenge traditional systems and scale access to vital healthcare technologies. Since its inception, Black Opal Ventures has evolved to emphasize the collision of industries—particularly healthcare and security—to generate transformational solutions with exponential impact. Their inaugural fund closed in late 2023, and the firm operates offices in New York City and San Francisco, running fellowship programs to engage emerging talent in venture capital and deepen their investment thesis development[1][2][3][4].
Black Opal Ventures rides the trend of deep tech innovation in healthcare, a sector facing escalating costs (projected to exceed $6 trillion in the U.S. by 2028) and significant unmet needs. By investing in companies that merge technological advances with healthcare challenges, they capitalize on market forces demanding precision, personalization, and accessibility in medical solutions. Their focus on the convergence of healthcare and security technologies positions them uniquely to influence systemic change and foster startups that can scale globally, addressing complex health and safety challenges[1][3].
Looking ahead, Black Opal Ventures is poised to expand its influence by continuing to back frontier tech startups that disrupt traditional healthcare paradigms. Trends such as AI-driven diagnostics, remote patient monitoring, and personalized medicine will likely shape their investment focus. Their fellowship programs suggest a commitment to cultivating talent and deepening expertise, which may enhance their deal sourcing and portfolio support. As healthcare and security sectors increasingly intersect, Black Opal Ventures’ role as a catalyst for innovation and systemic transformation is expected to grow, reinforcing their mission to build a "brilliant tomorrow"[1][2][3].
Key people at Black Opal Ventures.
